CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 37392-37707 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/038354e8830fe01feb621a12e8a8c467a15b6354","sourcedb":"CORD-19","sourceid":"038354e8830fe01feb621a12e8a8c467a15b6354","text":"It is anticipated that these methods will result in the development of live vaccines against RSV and hPIV3, which preferably would be given in the first weeks of life, and against hPIV1 and hPIV2, which cause disease somewhat later during the first year of life such that vaccination could begin at 6 months of age.","tracks":[{"project":"Epistemic_Statements","denotations":[{"id":"T84","span":{"begin":0,"end":315},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T84","pred":"source","obj":"Epistemic_Statements"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Epistemic_Statements","color":"#e6ec93","default":true}]}]}}